Ilka Peters

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Locally Advanced

Squamous Cell Carcinoma

Epidermal Growth Factor Receptor

Dna Damage Response

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Theodoros Kolokotronis, Britta Majchrzak-Stiller, Marie Buchholz, Vanessa Mense, Johanna Strotmann, Ilka Peters, Lea Skrzypczyk, Sven-Thorsten Liffers, Louise Massia Menkene, Mathias Wagner, Matthias Glanemann, Fay Betsou, Wim Ammerlaan, Ronny Schmidt, Christoph Schröder, Waldemar Uhl, Chris Braumann, Philipp Höhn
Differential miRNA and Protein Expression Reveals miR-1285, Its Targets TGM2 and CDH-1, as Well as CD166 and S100A13 as Potential New Biomarkers in Patients with Diabetes Mellitus and Pancreatic Adenocarcinoma. Cancers 16 (15) (2024)
Marie Buchholz, Britta Majchrzak-Stiller, Ilka Peters, Stephan A Hahn, Lea Skrzypczyk, Lena Beule, Waldemar Uhl, Chris Braumann, Johanna Strotmann, Philipp Höhn
Maintenance Therapy for Pancreatic Cancer, a New Approach Based on the Synergy between the Novel Agent GP-2250 (Misetionamide) and Gemcitabine. Cancers 16 (14) (2024)
Marie Buchholz, Britta Majchrzak-Stiller, Ilka Peters, Stephan A Hahn, Lea Skrzypczyk, Lena Beule, Waldemar Uhl, Chris Braumann, Johanna Strotmann, Philipp Höhn
Maintenance Therapy for Pancreatic Cancer, a New Approach Based on the Synergy between the Novel Agent GP-2250 (Misetionamide) and Gemcitabine. Cancers 16 (14) (2024)
Theodoros Kolokotronis, Britta Majchrzak-Stiller, Marie Buchholz, Vanessa Mense, Johanna Strotmann, Ilka Peters, Lea Skrzypczyk, Sven-Thorsten Liffers, Louise Massia Menkene, Mathias Wagner, Matthias Glanemann, Fay Betsou, Wim Ammerlaan, Ronny Schmidt, Christoph Schröder, Waldemar Uhl, Chris Braumann, Philipp Höhn
Differential miRNA and Protein Expression Reveals miR-1285, Its Targets TGM2 and CDH-1, as Well as CD166 and S100A13 as Potential New Biomarkers in Patients with Diabetes Mellitus and Pancreatic Adenocarcinoma. Cancers 16 (15) (2024)
Marie Buchholz, Britta Majchrzak-Stiller, Ilka Peters, Stephan A Hahn, Lea Skrzypczyk, Lena Beule, Waldemar Uhl, Chris Braumann, Johanna Strotmann, Philipp Höhn
Maintenance Therapy for Pancreatic Cancer, a New Approach Based on the Synergy between the Novel Agent GP-2250 (Misetionamide) and Gemcitabine. Cancers 16 (14) (2024)
Claudia Baron, Marie Buchholz, Britta Majchrzak-Stiller, Ilka Peters, Daniel Fein, Thomas Müller, Waldemar Uhl, Philipp Höhn, Johanna Strotmann, Chris Braumann
Substance GP-2250 as a New Therapeutic Agent for Malignant Peritoneal Mesothelioma-A 3-D In Vitro Study. International journal of molecular sciences 23 (13) (2022)
Marie Buchholz, Johanna Strotmann, Britta Majchrzak-Stiller, Stephan A Hahn, Ilka Peters, Julian Horn, Thomas Müller, Philipp Höhn, Waldemar Uhl, Chris Braumann
New Therapy Options for Neuroendocrine Carcinoma of the Pancreas-The Emergent Substance GP-2250 and Gemcitabine Prove to Be Highly Effective without the Development of Secondary Resistances In Vitro and In Vivo. Cancers 14 (11) (2022)